Berriman, James – Trademark Portfolio

Entity Type: 01

Berriman, James holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EVIDOX. The owner is based in Boston, MA.

No. 8

869 Beacon Street

Boston, MA 02215

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LEXABYTE
LEXABYTE
Abandoned 2018
EVIDOX
EVIDOX
Registered 2006
EVIDOX
EVIDOX
Registered 2006

Trademark Classifications

Berriman, James's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (1 filing)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Berriman, James have?

Berriman, James has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Berriman, James file in?

Berriman, James files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Berriman, James's most well-known trademarks?

Berriman, James's registered trademark portfolio includes well-known marks such as EVIDOX. These are among 2 currently registered trademarks in the portfolio.

What is Berriman, James's trademark registration success rate?

Berriman, James has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.